Not surprisingly, Ron DeSantis was right about Monoclonal-Antibody Therapy

National Review's Charlie Cooke writes, "Two months ago, Governor Ron DeSantis of Florida was being roundly castigated for promoting the use of Regeneron’s monoclonal-antibody treatment as part of his state’s efforts to fight COVID-19. Desperate to find something sinister in the push, DeSantis’s critics threw out every charge they could dream up. At first, the line was that Regeneron’s treatment didn’t work. Then, it was that Regeneron’s treatment worked fine, but represented a dangerous distraction from the vaccine. And, finally, it was that Regeneron’s treatment was part of a corrupt plot to enrich DeSantis’s donors.

Today, we learn from the Washington Post that, actually, none of that was the problem. Instead, DeSantis’s sin is that he has been relying upon monoclonal-antibody treatment too much, and that this is unfair to other states that now need it.

What a difference eight weeks make.

Ron DeSantis Was Right about Monoclonal-Antibody Therapy; Florida’s governor was blasted by progressives for promoting Regeneron’s COVID treatment. Now, demand is so great the Biden administration is rationing it https://t.co/gXq8CHKINP

— Tammy Bruce (@HeyTammyBruce) September 16, 2021

The Post informs us that the Biden administration has been so impressed by the impact that Regeneron’s treatment has made that it is now seeking to 'stave off shortages' of the drug by 'purchasing 1.4 million additional doses' and tasking the Department of Health and Human Services with setting 'the rules for distribution . . . instead of allowing states, medical facilities and doctors to order them directly.' In explaining this move, the Post submits that 'soaring demand for the therapy represents a sharp turn from just two months ago, when monoclonal antibodies were widely available and awareness of them was low' — which . . . is certainly one way of admitting that the same people who relentlessly condemned DeSantis for trying to raise that 'awareness' 'just two months ago' are today coming around to his point of view.

Read the entire column.